Clinical Trials for Prinicipal Investigator: Elizabeth A Brem

3 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
ECOG-E1A11 (CIRB) Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE) Open
UCI-14-96 UCReliance#1265: A Phase I/II Study of PiC-D (Ixazomib in Combination with Pomalidomide, Clarithromycin and Dexamethasone) in Patients with Double Refractory Multiple Myeloma Open
UCI-16-70 Evaluation of Mitochondrial Priming in T Cell Lymphomas Open